VF
TXG icon

VitalStone Financial’s 10x Genomics TXG Stock Holding History

VitalStone Financial’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$352K Buy
15,582
+15,546
+43,183% +$321K 0.24% 81
2024
Q2 		$700 Sell
36
-29
-45% -$759 ﹤0.01% 430
2024
Q1 		$2K Sell
65
-3,535
-98% -$155K ﹤0.01% 411
2023
Q4 		$201K Buy
3,600
+3,594
+59,900% +$156K 0.16% 90
2023
Q3 		$0 Hold
6
– – ﹤0.01% 642
2023
Q2 		$0 Hold
6
– – ﹤0.01% 1052
2023
Q1 		$1K Hold
6
– – ﹤0.01% 353
2022
Q4 		$0 Buy
+6
New +$196 ﹤0.01% 594

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

VitalStone Financial's TXG Position: Q3 2024 in Review

VitalStone Financial increased its 10x Genomics (TXG) stake by 43,183% in Q3 2024, buying an estimated $321K and bringing the position to 15,582 shares worth $352K. The position accounts for 0.24% of the portfolio, ranked #81.

VitalStone Financial first reported a position in TXG in Q4 2022 and has held it in 8 quarters since. 266 funds tracked by Wall St. Rank hold TXG as of Q3 2024.

  • VitalStone Financial held 15,582 shares of 10x Genomics worth $352K as of Q3 2024.
  • VitalStone Financial bought 15,546 10x Genomics shares in Q3 2024, an estimated $321K.
  • 10x Genomics made up 0.24% of VitalStone Financial's portfolio in Q3 2024, its #81 holding.
  • VitalStone Financial first reported a position in 10x Genomics in Q4 2022 and has held it in 8 quarters since.
  • 266 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2024.

Based on VitalStone Financial's 13F filing for Q3 2024, filed 11 Oct 2024.